166 related articles for article (PubMed ID: 7862624)
21. p53-dependent induction of WAF1 by cold shock in human glioblastoma cells.
Ohnishi T; Wang X; Ohnishi K; Takahashi A
Oncogene; 1998 Mar; 16(11):1507-11. PubMed ID: 9525749
[TBL] [Abstract][Full Text] [Related]
22. Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.
Gurova KV; Rokhlin OW; Budanov AV; Burdelya LG; Chumakov PM; Cohen MB; Gudkov AV
Cancer Res; 2003 Jun; 63(11):2905-12. PubMed ID: 12782597
[TBL] [Abstract][Full Text] [Related]
23. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.
Marutani M; Tonoki H; Tada M; Takahashi M; Kashiwazaki H; Hida Y; Hamada J; Asaka M; Moriuchi T
Cancer Res; 1999 Oct; 59(19):4765-9. PubMed ID: 10519380
[TBL] [Abstract][Full Text] [Related]
24. The p53 gene and its role in human brain tumors.
Bögler O; Huang HJ; Kleihues P; Cavenee WK
Glia; 1995 Nov; 15(3):308-27. PubMed ID: 8586466
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
26. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.
Jung JM; Li H; Kobayashi T; Kyritsis AP; Langford LA; Bruner JM; Levin VA; Zhang W
Cell Growth Differ; 1995 Aug; 6(8):909-13. PubMed ID: 8547219
[TBL] [Abstract][Full Text] [Related]
28. Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule.
Biroccio A; Bufalo DD; Ricca A; D'Angelo C; D'Orazi G; Sacchi A; Soddu S; Zupi G
Gene Ther; 1999 Jun; 6(6):1064-72. PubMed ID: 10455409
[TBL] [Abstract][Full Text] [Related]
29. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
[TBL] [Abstract][Full Text] [Related]
30. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
[TBL] [Abstract][Full Text] [Related]
31. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
[TBL] [Abstract][Full Text] [Related]
32. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
33. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells.
Van Meir EG; Polverini PJ; Chazin VR; Su Huang HJ; de Tribolet N; Cavenee WK
Nat Genet; 1994 Oct; 8(2):171-6. PubMed ID: 7531056
[TBL] [Abstract][Full Text] [Related]
34. The 273rd codon mutants of p53 show growth modulation activities not correlated with p53-specific transactivation activity.
Kawamura M; Yamashita T; Segawa K; Kaneuchi M; Shindoh M; Fujinaga K
Oncogene; 1996 Jun; 12(11):2361-7. PubMed ID: 8649776
[TBL] [Abstract][Full Text] [Related]
35. Genetic instability leads to loss of both p53 alleles in a human glioblastoma.
Albertoni M; Daub DM; Arden KC; Viars CS; Powell C; Van Meir EG
Oncogene; 1998 Jan; 16(3):321-6. PubMed ID: 9467957
[TBL] [Abstract][Full Text] [Related]
36. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
37. Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis.
Reichert M; Steinbach JP; Supra P; Weller M
Cancer; 2002 Sep; 95(5):1113-9. PubMed ID: 12209698
[TBL] [Abstract][Full Text] [Related]
38. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
39. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H
Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969
[TBL] [Abstract][Full Text] [Related]
40. Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor.
Tian XX; Chan JY; Pang JC; Chen J; He JH; To TS; Leung SF; Ng HK
Br J Cancer; 1999 Nov; 81(6):994-1001. PubMed ID: 10576656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
